v3.26.3
Condensed Statements of Cash Flows - USD ($)
3 Months Ended
Sep. 30, 2026
Sep. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (5,742,936) $ (1,785,058)
Adjustments to reconcile net loss to net cash used in operating activities    
Preferred shares issued as compensation 11,449 11,632
Common shares issued as compensation and for services 38,250 38,250
Warrants granted to Scientific Advisory Board 139 135
Depreciation 126,123 130,752
Amortization 2,068 2,068
Changes in operating assets and liabilities:    
Prepaid expenses (36,534) (14,709)
Other assets 357 358
Accounts payable 203,841 (57,301)
Accounts payable - related parties (124,136) 79,687
NET CASH USED IN OPERATING ACTIVITIES (3,641,381) (1,593,855)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment   (84,317)
NET CASH USED IN INVESTING ACTIVITIES   (84,317)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Net proceeds from sale of common stock 3,422,498 1,245,319
NET CASH PROVIDED BY FINANCING ACTIVITIES 3,422,498 1,245,319
NET CHANGE IN CASH AND CASH EQUIVALENTS (218,883) (432,853)
Cash and cash equivalents at beginning of period 2,794,110 1,558,564
Cash and cash equivalents at end of period 2,575,227 1,125,711
NON CASH FINANCING AND INVESTING ACTIVITIES:    
Issuance of common stock for services rendered   146,850
Nonrelated party    
Changes in operating assets and liabilities:    
Accrued expenses 680,603 $ 331
Related party    
Changes in operating assets and liabilities:    
Accrued expenses $ 1,199,395